Skip to main content
SpringerLink
Log in

Treatment of Vascular Damage in Exoerimental Malignant Hypertension with Nifedipine and its Calcium

  • Conference paper
Primary Hypertension

Abstract

Calcium antagonists — a new group of antihypertensive drugs — are known to prevent damage of heart muscle due to ischemia, hypoxia, increased sympathetic drive, and other stimuli by preventing the deleterious calcium overload of the cell (for review, see [1, 2])

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fleckenstein A, Fleckenstein-Grün G (1980) Cardiovascular protection by Ca2+-antagonists. Eur Heart J [Suppl B] 1: 15–21

    CAS  Google Scholar 

  2. Nayler WG, Ferrari F, Slade A (1980) Cardioprotective actions of calcium-antagonists in myo-cardial anoxia and ischaemia., In: Fleckenstein A, Roskamm H (eds) Calcium-Antagonismus. Springer, Berlin Heidelberg New York, pp 119–137

    Google Scholar 

  3. Dahl LK (1961) Effect of chronic salt feeding. Induction of selfsustaining hypertension in rats., J Exp Med 114: 231–235

    Article  PubMed  CAS  Google Scholar 

  4. Dahl LK, Heine M, Tassinari L (1962) Effect of chronic salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension., J Exp Med 115: 1173–1190

    Google Scholar 

  5. Dahl LK, Heine M, Thompson K (1972) Genetic influence of renal homografts on blood pressure of rats from different strains. Proc Soc Exp Biol Med 140: 852–2854

    PubMed  CAS  Google Scholar 

  6. Tobian L, Lange J, Azar S, Iwai J, Koop D, Coffee K, Johnson MA (1978) Reduction of natriuretic capacity and renin-release in isolated, blood perfused kidneys of Dahl hypertension- prone rats. Circ Res [Suppl 1] 43:I-92–I-98

    Google Scholar 

  7. Tobian L, Lange J, Iwai J, Hiller K, Johnson MA, Goossens P (1979) Prevention with thiazide of NaCl-induced hypertension in Dahl “S” rats. Evidence for a Na-retaining agent in “S” rats. Hypertension 1: 316–323

    Google Scholar 

  8. Jaffe S, Sutherland LE, Barker DM, Dahl LK (1970) Effect of chronic salt ingestion. Morphologic findings in kidneys of rats with differing genetic susceptibilities to hypertension., Arch Pathol 90: 1–16

    Google Scholar 

  9. Luckhaus G, Garthoff B, Kazda S (1982) Prevention of hypertensive vasculopathy by nifedipine in salt-loaded Dahl rats. Arzneimittelforsch 32: 1421–1425

    PubMed  CAS  Google Scholar 

  10. Kazda S, Garthoff B, Luckhaus G, Nash G (1982) Influence of nifedipine on hypertensive morphological changes in rats. In: Kaltenbach M, Neufeld HN (eds) 5th International Adalat Symposium. New therapy of ischaemic heart disease and hypertension. Excerpta Medica, Amsterdam, pp 133–143

    Google Scholar 

  11. Kazda S, Garthoff B, Dycka J, Iwai I (1982) Prevention of malignant hypertension in salt-loaded “S” Dahl rats with the calcium antagonist nifedipine. Clin Exp Hypertens [A] 4 (7): 1231–1241

    Article  CAS  Google Scholar 

  12. Garthoff B, Kazda S (1982) Prevention and reversal of salt-induced hypertension in DS-Dahl rats by nisoldipine. Fed Proc 41: 1664

    Google Scholar 

  13. Kazda S, Garthoff B, Knorr A (1983) Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension. Fed Proc 42: 196–200

    PubMed  CAS  Google Scholar 

  14. Rapp JR (1982) Dahl salt susceptible and salt resistant rats: a review. Hypertension 4: 753–763

    PubMed  CAS  Google Scholar 

  15. Kazda S, Garthoff B (1982) Management of salt-induced hypertension in Dahl-rats by use of the calcium antagonist nifedipine. In: Iwai J (ed) Salt and hypertension. Igaku-Shoin, Tokyo, pp 51–53

    Google Scholar 

  16. Kazda S, Garthoff B, Luckhaus G, Nash G (1983) The calcium antagonist nifedipine and its analogues preserve tissue integrity and increase life span in experimental malignant hypertension. In: Hashimoto K, Kawai C (eds) Asian Pacific Adalat Symposium. New Therapy of Ischemic Heart Disease and Hypertension., Medical Tribune, Tokyo, pp 50–62

    Google Scholar 

  17. Kazda S, Garthoff B, Luckhaus G (1983) Calcium antagonists in hypertensive disease: experimental evidence for a new therapeutic concept. Postgrad Med J [Suppl 2] 59: 78–83

    CAS  Google Scholar 

  18. Luckhaus G, Nash G, Garthoff B, Kazda S, Feller W (1985) Healing of malignant hypertensive arteriopathy in Dahl rats by nifedipine. Arzneimittelforsch 35: 115–121

    PubMed  CAS  Google Scholar 

  19. Okamoto K, Yamori Y, Nagaoka A (1974) Establishment of the stroke-prone spontaneously hypertensive rat (SHR) Circ Res [Suppl 1] 34 /35: 143–153

    Google Scholar 

  20. Kazda S, Hoffmeister F, Garthoff B, Towart R (1979) Prevention of the postischaemic impaired reperfusion on the brain by nimodipine (BAY E 9736). Acuta Neurol Scand [Suppl 72] 60: 302–303

    Google Scholar 

  21. Fleckenstein A, Frey M, von Witzleben H (1983) Vascular calcium overload — a pathogenic factor in arteriosclerosis and its neutralization by calcium antagonists. In: Kaltenbach M, Neufeld HN (eds) 5th International Adalat Symposium. New therapy of ischaemic heart disease and hypertension. Excerpta Medica, Amsterdam, pp 36–54

    Google Scholar 

  22. Borle AB (1973) Calcium metabolism at the cellular level. Fed Proc 32: 1944–1950

    PubMed  CAS  Google Scholar 

  23. Nickerson PA, Conran RM (1981) Parathyroidectomy ameliorates vascular lesions induced by deoxycorticosterone in the rat. Am J Pathol 105: 185–190

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, Bayer AG, Aprather Weg, Wuppertal 1, D-5600, Germany

    S. Kazda & B. Garthoff

  2. Institute of Toxicology, Bayer AG, Aprather Weg, Wuppertal 1, D-5600, Germany

    G. Luckhaus

Authors
  1. S. Kazda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Garthoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Luckhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine II, Merheim Hospital and Policlinic of the University of Cologne, Ostmerheimer Str. 200, D-5000, Köln 91, Germany

    Werner Kaufmann , Gerd Bönner , Robert Lang  & Karl August Meurer , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kazda, S., Garthoff, B., Luckhaus, G. (1986). Treatment of Vascular Damage in Exoerimental Malignant Hypertension with Nifedipine and its Calcium. In: Kaufmann, W., Bönner, G., Lang, R., Meurer, K.A. (eds) Primary Hypertension. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71125-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71125-1_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16390-9

  • Online ISBN: 978-3-642-71125-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation